Age: 59.0
Sex: F
Vaccine: COVID19, FLUX
Symptoms: Blood urine present, Off label use, Product use issue, Urine analysis
Clinical narrative: Blood in urine; Other vaccine same date product: Flu, Other vaccine same date vaccine date: 30Sep2022; Other vaccine same date product: Flu, Other vaccine same date vaccine date: 30Sep2022; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 30Sep2022 at 17:30 as dose 5 (booster), single (Lot number: GJ3277) at the age of 59 years, in left arm for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), on 30Sep2022 as dose number unknown, single (Batch/Lot number: unknown), in left arm. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "High cholesterol" (unspecified if ongoing); "Penicillin allergy" (unspecified if ongoing); "Turkey" (unspecified if ongoing), notes: Known allergies: Turkey. Concomitant medication(s) included: CRESTOR; EZETIMIBE; NEBIVOLOL; ASPIRIN [ACETYLSALICYLIC ACID]. Past drug history included: Tetracycline, reaction(s): "Drug allergy", notes: Known allergies: Tetracycline; Ibuprofen, reaction(s): "Drug allergy", notes: Known allergies: Ibuprofen. Vaccination history included: BNT162b2 (DOSE 4 (BOOSTER), SINGLE, Batch/Lot No: FP4554, Location of injection: Arm Left, Vaccine Administration Time: 05:30 PM), administration date: 08Apr2022, when the patient was 59-year-old, for COVID-19 immunization; BNT162b2 (DOSE 3 (BOOSTER), SINGLE, Batch/Lot No: FH8020, Location of injection: Arm Left, Vaccine Administration Time: 02:00 PM), administration date: 31Oct2021, when the patient was 58-year-old, for COVID-19 immunization; BNT162b2 (DOSE 2, SINGLE, Batch/Lot No: EW0162, Location of injection: Arm Left, Vaccine Administration Time: 05:30 PM), administration date: 21Apr2021, when the patient was 58-year-old, for COVID-19 immunization; BNT162b2 (DOSE 1, SINGLE, Batch/Lot No: ER8734, Location of injection: Arm Left, Vaccine Administration Time: 04:30 PM), administration date: 31Mar2021, when the patient was 58-year-old, for COVID-19 immunization. The following information was reported: OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 30Sep2022, outcome "unknown" and all described as "Other vaccine same date product: Flu, Other vaccine same date vaccine date: 30Sep2022"; BLOOD URINE PRESENT (medically significant) with onset 19Oct2022 at 12:00, outcome "recovering", described as "Blood in urine". The event "blood in urine" required physician office visit. The patient underwent the following laboratory tests and procedures: Urine analysis: (19Oct2022) Blood in urine. Therapeutic measures were taken as a result of blood urine present.  Clinical course: Blood in urine, had happened anywhere from 1 day to 2 plus weeks after injections. Did not put it together until mom also had at same time this week and they were both vaccinated on same day. Patient took antibiotic treatment. No Covid prior vaccination, patient did not tested positive for covid-19 post vaccination. Patient took Vitamin in two weeks. Patient did not receive any other vaccine in four weeks.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201246697 Same reporter/vaccine/event, different patient;